Join
Live feed
·
INSIDERFilingvia Quantisnow
Alnylam Pharmaceuticals Inc. logo

Chief Executive Officer Greenstreet Yvonne sold $3,475,157 worth of shares (9,577 units at $362.86) and was granted 19,003 shares, increasing direct ownership by 14% to 78,411 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALNY (Alnylam Pharmaceuticals Inc.) and more on Quantisnow.